Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

被引:73
作者
Galani, Irene [1 ,3 ]
Nafplioti, Konstantina [1 ]
Adamou, Panagiota [1 ]
Karaiskos, Ilias [2 ]
Giamarellou, Helen [2 ]
Souli, Maria [1 ]
Maraki, Sofia [4 ]
Mauromanolaki, Viktoria Eirini [4 ]
Papaioannou, Vassiliki [5 ]
Tsiplakou, Sofia [5 ]
Kazila, Polyzo [6 ]
Diamanti, Ioanna [6 ]
Charalampaki, Nikoletta [7 ]
Trikka-Graphakos, Eleftheria [7 ]
Toutouza, Marina [8 ]
Vagiakou, Helen [9 ]
Pappas, Konstantinos [10 ]
Kyratsa, Anna [11 ]
Paschali, Angeliki [11 ]
Kontopoulou, Konstantina [12 ]
Legga, Olga [13 ]
Petinaki, Efthymia [14 ]
Papadogeorgaki, Helen [15 ]
Chinou, Efrosini [16 ]
机构
[1] Univ Athens, Infect Dis Lab, Dept Internal Med 4, Fac Med, Athens, Greece
[2] Hygeia Hosp, Dept Internal Med 6, Athens, Greece
[3] Univ Gen Hosp ATTIKON, Rimini 1, Chaidari 12462, Greece
[4] Univ Hosp Heraklion, Dept Clin Bacteriol Parasitol Zoonoses & Geog Med, Iraklion, Greece
[5] KAT Hosp, Dept Microbiol, Athens, Greece
[6] Canc Hosp Thessaloniki THEAGENEIO, Thessaloniki, Greece
[7] THRIASSIO Gen Hosp, Dept Clin Microbiol, Athens, Greece
[8] Hippokrat Athens Gen Hosp, Dept Microbiol, Athens, Greece
[9] Gen Hosp Athens G Gennimatas, Microbiol Lab, Athens, Greece
[10] Athens Naval Hosp, Athens, Greece
[11] Gen Hosp Corfu, Microbiol Lab, Corfu, Greece
[12] Gen Hosp Thessaloniki G Gennimatas, Dept Microbiol, Thessaloniki, Greece
[13] Gen Hosp Lamia, Dept Microbiol, Lamia, Greece
[14] Univ Hosp Larissa, Dept Microbiol, Larisa, Greece
[15] Hygeia Gen Hosp, Microbiol Lab, Athens, Greece
[16] St Savvas Canc Hosp, Dept Microbiol, Athens, Greece
关键词
Plazomicin; K; pneumoniae; Carbapenemase; Greece; MODIFYING ENZYMES; ESCHERICHIA-COLI; ENTEROBACTERIACEAE; EMERGENCE; SPECTRUM; STRAINS;
D O I
10.1186/s12879-019-3801-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundTo evaluate the in vitro activities of plazomicin and comparator aminoglycosides and elucidate the underlying aminoglycoside resistance mechanisms among carbapenemase-producing K. pneumoniae isolates collected during a nationwide surveillance study in Greek hospitals.MethodsThree hundred single-patient carbapenemase-producing K. pneumoniae isolates were studied, including 200 KPC-, 50 NDM-, 21 VIM-, 14 KPC & VIM-, 12 OXA-48-, two NDM & OXA- and one KPC & OXA-producing isolates. Susceptibility testing was performed by broth microdilution, and minimum inhibitory concentrations (MICs) interpreted per EUCAST breakpoints. Carbapenemase-, aminoglycoside modifying enzyme- and 16S rRNA methylase- encoding genes were detected by PCR.ResultsOf 300 isolates tested, 5.7% were pandrug resistant and 29.3% extensively drug resistant. Plazomicin inhibited 87.0% of the isolates at 2mg/L, with MIC50/MIC90 of 0.5/4mg/L. Apramycin (a veterinary aminoglycoside) inhibited 86.7% of the isolates at 8mg/L and was the second most active drug after plazomicin, followed by gentamicin (S, 43%; MIC50/MIC90, 4/>256) and amikacin (S, 18.0%; MIC50/MIC90, 32/128). Twenty-three (7.7%) isolates (16 KPC-, 6 VIM- and one KPC & OXA-48-producers) exhibited MICs 64mg/L for plazomicin, and harbored rmtB (n=22) or armA (n=1). AAC(6)-b was the most common aminoglycoside modifying enzyme (84.7%), followed by AAC(3?)-IIa (25.3%), while those two enzymes were co-produced by 21.4% of the isolates.ConclusionsPlazomicin retains activity against most carbapenemase-producing K. pneumoniae isolated from Greek hospitals, with MICs consistently lower than those of the other aminoglycosides, even in the presence of aminoglycoside modifying enzymes. Dissemination of 16S- rRNA methylases in 8% of the isolates is an unwelcome event that needs strict infection control measures and rigorous stewardship interventions.
引用
收藏
页数:12
相关论文
共 29 条
[1]   Synthesis and Spectrum of the Neoglycoside ACHN-490 [J].
Aggen, James B. ;
Armstrong, Eliana S. ;
Goldblum, Adam A. ;
Dozzo, Paola ;
Linsell, Martin S. ;
Gliedt, Micah J. ;
Hildebrandt, Darin J. ;
Feeney, Lee Ann ;
Kubo, Aya ;
Matias, Rowena D. ;
Lopez, Sara ;
Gomez, Marcela ;
Wlasichuk, Kenneth B. ;
Diokno, Raymond ;
Miller, George H. ;
Moser, Heinz E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (11) :4636-4642
[2]   Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents [J].
Almaghrabi, Reem ;
Clancy, Cornelius J. ;
Doi, Yohei ;
Hao, Binghua ;
Chen, Liang ;
Shields, Ryan K. ;
Press, Ellen G. ;
Iovine, Nicole M. ;
Townsend, Bethany M. ;
Wagener, Marilyn M. ;
Kreiswirth, Barry ;
Nguyen, M. Hong .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (08) :4443-4451
[3]  
[Anonymous], 2004, M31S1 NCCLS
[4]  
[Anonymous], 2015, M07A10 CLSI
[5]   Characterization of Tn3000, a Transposon Responsible for blaNDM-1 Dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India [J].
Campos, Juliana Coutinho ;
Felix da Silva, Maria Jose ;
Nascimento dos Santos, Paulo Roberto ;
Barros, Elaine Menezes ;
Pereira, Mayne de Oliveira ;
Silva Seco, Bruna Mara ;
Magagnin, Cibele Massotti ;
Leiroz, Leonardo Kalab ;
Mimary de Oliveira, Theo Gremen ;
de Faria-Junior, Celio ;
Cerdeira, Louise Teixeira ;
Barth, Afonso Luis ;
Ferreira Sampaio, Suely Carlos ;
Zavascki, Alexandre Prehn ;
Poirel, Laurent ;
Mello Sampaio, Jorge Luiz .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (12) :7387-7395
[6]  
CLSI, 2018, M100 PERFORMANCE STA
[7]   Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes [J].
del Carmen Lopez-Diaz, Maria ;
Culebras, Esther ;
Rodriguez-Avial, Iciar ;
Rios, Esther ;
Manuel Vinuela-Prieto, Jose ;
Picazo, Juan J. ;
Rodriguez-Avial, Carmen .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (02)
[8]   Aminoglycoside Resistance The Emergence of Acquired 16S Ribosomal RNA Methyltransferases [J].
Doi, Yohei ;
Wachino, Jun-ichi ;
Arakawa, Yoshichika .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2016, 30 (02) :523-+
[9]  
European Society of Clinical Microbiology and Infectious Diseases, 2018, CLIN BREAKP VERS 8 0
[10]   Aminoglycoside antibiotic [J].
Galani, I. .
DRUGS OF THE FUTURE, 2014, 39 (01) :25-35